compounded glp-1 drugs Weight Loss Treatment GLP-1 online advertising overstates benefits

Cardiovasc Diabetol (2022) 21:169

As a result, simply injecting GLP-1 itself was impractical it would be cleared before having sustained benefit

Two randomized control clinical trials reported conflicting effects on bone mineral content (BMC) and bone mineral density (BMD): one trial demonstrated preservation of BMC with GLP-1 use, while the other found no significant difference in BMC or BMD between treatment and control groups

The honest estimate from practitioners using this approach is that roughly 60 to 70% of patients see some degree of improvement, while 30 to 40% see no meaningful change

(27) Additionally, GLP-1 agonists were linked to lower hospitalization rates, mortality, and a reduced risk of lower limb amputation (HR: 0.83, 95% CI: 0.671.03)

Here is a professional breakdown of how to choose the right path with your healthcare provider